3 Key Trends Shaping the Future of the CDMO Industry: Insights from our CEO, Andreas Raabe

In an exclusive interview with Contract Pharma, Andreas Raabe, CEO of Adragos Pharma, reveals three key trends that will redefine the contract development and manufacturing organisation (CDMO) industry in the future. Below is a summary of the interview, highlighting the […]

Women in Science: Aurélie Thénault’s Journey at Adragos Pharma   

In an industry as dynamic and challenging as pharmaceuticals, women like Aurélie Thénault are bringing change and leading the charge toward innovation. Aurélie, operational excellence and lean manager at Adragos Pharma’s Livron facility, exemplifies what it means to be a […]

New Pharmaceutical Filling Machines: Innovation at Our Leipzig Facility 

The pharmaceutical industry constantly seeks innovations to improve efficiency, product quality, and sterility. Pharmaceutical filling machines are critical in achieving these goals. In this blog post, we will delve into the recent advancements at our Leipzig facility, where two new […]

The Evolution of Adragos Pharma 

Adragos Pharma stands as the protagonist in the pharmaceutical industry, offering an integrated array of services that span the entire lifecycle of drug development and manufacturing. As the company journey towards a vision of revolutionizing pharmaceutical solutions globally, it’s imperative to […]

Aseptic Filling Machine: The Future of Pharma Automation 

The pharmaceutical industry continuously evolves to meet the increasing demands for sterile and safe drug production. An essential innovation driving this evolution is the Aseptic Filling Machine, which plays a critical role these machines play in ensuring product integrity and […]

What is HPAPI and How to Mitigate Its Production Risks 

HPAPI is increasingly being explored as a strategy for targeted therapy and are changing the face of the pharmaceutical industry by providing innovative solutions for the treatment of diseases. From oncological therapies to antidiabetic and CNS disorder drugs, HPAPI is […]

Subscribe to our newsletter!

Get notified on our latest news.